November 2025 Newsletter

The Critical Crossroads: Technology Driving Precision Medicine in the Pre-Analytical Phase

Precision medicine, the revolutionary approach of tailoring treatments based on an individual’s unique characteristics, relies entirely on accurate, high-quality data. This data spans two crucial domains: the genomic scope (an individual’s DNA and RNA) and the phenomic scope (observable physical and biochemical characteristics, symptoms, and environmental interactions). While significant advancements have been made in sequencing and analytical technology, the reliability of a precision diagnosis is often determined long before the sample enters the analyzer, in the pre-analytical phase or pre-lab testing. New technological advances, from sophisticated automation to intelligent data tracking are now focusing intensely on this initial error-prone stage, to ensure the promise of personalized care is met with reliable, actionable results.

Want to read on? Join our network and receive access to our member-only newsletter.

As a member of Global Health Impact Network, you'll enjoy full access to the newsletter, featuring exclusive industry insights, network updates, and opportunities to consult, advise, and invest. Don’t miss out — join today and unlock your benefits.